Navigation Links
Royal College Issues Revised Guidelines for Face Transplantation

In the light of new information on facial transplantation—including the psychological and ethical aspects// of the controversial procedure—a Working Party of the Royal College of Surgeons of England now endorses moving cautiously forward in performing further face transplants, according to a report published in the Jan. 27 issue of Transplantation.

In its initial report in 2003, the Working Party concluded that facial transplantation should not be attempted until further research was done to define the risks. The new report cites several new developments since then—most significantly, the encouraging results of a partial face transplant procedure performed by a French surgical team. The panel also notes progress in experimental studies of facial transplantation and more follow-up information on patients undergoing hand transplantation and other types of "composite" transplant procedures.

The past few years have also seen "a deepening understanding of the potential psychological problems of facial transplantation as well as a very considerable debate on the ethical aspects of the procedure." The new report states, "[T]he working party now accepts its inevitability but endorses the urgency of establishing sound ethical principles" for performing face transplants.

As in 2003, the technical skill to perform face transplantation is not at issue. Rather, the obstacle is the high risk that the recipient's immune system will reject the transplanted tissues. Recipients require lifelong immunosuppressive drug treatment to prevent rejection. Updated experience with hand transplants, as well as the French face transplant recipient, suggests that close monitoring and treatment adjustments can head off problems with acute rejection. However, the risks of chronic (long-term) rejection remains unknown—based on experience with other types of transplants, a 30 to 50 percent risk seems "a reasonable estimate."

The report cites the many p sychological issues that face transplant recipients must confront, including unrealistic expectations, the risk of devastating transplant failure, and the reactions of others to their altered appearance. Face transplantation also entails a host of social issues—including "invasive press interest and publicity," as demonstrated by the French case.

The panel reiterate their concerns about the ethical aspects of face transplantation, including the difficulty of obtaining valid patient consent when the risks of the operation are simply unknown—the "Catch-22" of needing to proceed with research in order properly to establish the risk of an experimental procedure.

To address these concerns and provide protections for patients, the report lists recommended standards for any surgical team contemplating a facial transplant procedure. Of course, the surgeons and hospital must have the skill and ability to provide optimal surgical and medical care. There must be set procedures for patient selection, as well as for presenting the risks in a way that allows patients to make a true informed decision.

Expert psychological care must be provided for patients before and after transplantation—including arrangements for long-term psychological support, whether the procedure is a success or failure. The guidelines also call for care and support for family members of both the transplant donor and recipient.

Adequate long-term funding for all aspects of care must be provided, without compromising care for other patients in need. The recommendations also address concerns about the availability of independent experts, who should be included on the review committees that will consider applications for facial transplant procedures. "If all of these requirements are met, review committees might reasonably take the view that individual patients may proceed with facial transplantation in an appropriately regulated research setting," the Working Pa nel concludes.

We hope that the second edition of our report, including the minimal requirements we define, will allow face transplantation to progress in a rational way that protects the interests of vulnerable patients," comments Sir Peter Morris of the Royal College of Surgeons of England and the Centre for Evidence in Transplantation, London School of Hygiene and Tropical Medicine. "Face transplantation raises a number of complex medical, ethical, and psychological issues, and we encourage others both inside and particularly outside the transplant community to review and comment on our review and recommendations."


Related medicine news :

1. A Royal Flush And A White Elephant
2. Nursing A Threat : NHS Nurses May Stage A Royal Protest
3. Sandwich Royale, Adorns Shelves of Selfridges in London
4. Royal Highland Show Cancelled Over Bird Flu Fears
5. Muhammad Ali In Battle Royale With Obesity
6. Royal Brompton Hospital Finds A New Technique To Detect Child Heart Killer
7. Grant of $7 million for Orissa Medical College from Japan
8. Orissa To Get New Medical Colleges Soon
9. Kottayam Medical College To be Upgraded
10. Kasturba Medical College Organizes CME- Orth 2005 From 4th To 6th November
11. Disadvantaged Students May Not Go In For College Education
Post Your Comments:

(Date:11/25/2015)... , ... November 25, 2015 , ... ... has been recognized once again for its stellar workplace culture with the company’s ... , Medical Solutions’ Cincinnati office was named a finalist in Cincinnati ...
(Date:11/25/2015)... (PRWEB) , ... November 26, 2015 , ... ... Union Commission (AUC), European Union (EU), ANDI Pan African Centres of Excellence, and ... Office in Nairobi (UNON) for the opening of the 5th African Network for ...
(Date:11/25/2015)... , ... November 25, 2015 , ... According to an ... robot is being more and more widely heralded as a breakthrough for performing hernia ... method has over traditional laparoscopic surgery is that it can greatly reduce the pain ...
(Date:11/25/2015)... ... November 25, 2015 , ... On November 25, 2015, ... for the Narconon network, announced the release of a new cutting edge recovery program ... organization has been working with drug- and alcohol-addicted individuals with the purpose to free ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
(Date:11/25/2015)...  Trovagene, Inc. (NASDAQ: TROV ), a developer ... Officer Antonius Schuh, Ph.D., is scheduled to present a ... Jaffray Healthcare Conference. th Annual Piper ... in New York on Tuesday, ... will be available for one-on-one meetings during the conference. ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: ... and Rugen Therapeutics, a start-up  biotechnology company focused ... CNS disorders and funded by the F-Prime Biomedical ... entered into an exclusive collaboration to support the ... Spectrum Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
Breaking Medicine Technology: